🔗 Share this article

This year's prestigious award in medical science has been awarded for revolutionary findings that illuminate how the body's defense network attacks harmful infections while sparing the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

Their work uncovered unique "security guards" within the immune system that eliminate rogue immune cells that could attacking the body.

The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.

These laureates will divide a prize fund valued at 11m SEK.

Crucial Discoveries

"The work has been essential for understanding how the body's defenses functions and the reason we do not all develop serious self-attack conditions," stated the head of the Nobel Committee.

The team's studies address a core question: In what way does the immune system defend us from numerous invaders while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for signs of infection, even viruses and germs it has not met before.

Such defenders utilize sensors—called receptors—that are generated by chance in countless variations.

That provides the immune system the capacity to combat a broad range of threats, but the unpredictability of the mechanism inevitably produces immune cells that may attack the host.

Protectors of the Immune System

Scientists previously understood that a portion of these problematic defense cells were destroyed in the thymus—the site where immune cells develop.

This year's award honors the discovery of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize any defenders that attack the healthy cells.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A prize committee stated, "These discoveries have established a new field of research and accelerated the development of new therapies, for instance for tumors and immune disorders."

In malignancies, T-regs prevent the body from attacking the tumor, so studies are focused on reducing their quantity.

In self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer under attack. A comparable approach could also be effective in minimizing the chances of organ transplant rejection.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing defense cells from healthy animals could stop the disease—suggesting there was a system for blocking immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an genetic autoimmune disease in mice and humans that resulted in the discovery of a gene critical for how regulatory T-cells operate.

"The pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a prominent biological science expert.

"The work is a remarkable example of how fundamental biological study can have broad consequences for human health."